Challenges in implementing the 2020 EULAR Points to Consider on nonadherence in RMDs

Low or nonadherence to treatment is a widespread challenge in the management of rheumatic and musculoskeletal diseases (RMDs), significantly affecting disease outcomes, quality of life, and healthcare costs. The 2020 European Alliance of Associations for Rheumatology (EULAR) Points to Consider provide a comprehensive framework for the prevention, screening, assessment, and management of nonadherence in RMDs. However, real-world implementation of these recommendations remains limited. The challenge is no longer the lack of recommendations, but their integration into routine rheumatology care. This viewpoint discusses the rationale and evidence supporting implementation of the 2020 EULAR Points to Consider in clinical practice and highlights key priorities for the operationalisation of the recommendations into feasible and sustainable care strategies. Particular emphasis is placed on routine adherence assessment, patient-centred communication, multidisciplinary collaboration, and healthcare professional training as essential components of adherence support in RMD care.

Authors

Institutions

Publication Details

Journal
EULAR Rheumatology Open
Published
2026-10-15
DOI
https://doi.org/10.1016/j.ero.2026.100261
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges in implementing the 2020 EULAR Points to Consider on nonadherence in RMDs

Emma Dures, Eric HACHULLA, Ilaria Galetti, Carlo Salvarani et al.
EULAR Rheumatology Open
Medication Adherence and Compliance
article

Challenges in implementing the 2020 EULAR Points to Consider on nonadherence in RMDs

Emma Dures, Eric HACHULLA, Ilaria Galetti, Carlo Salvarani, Rosaria Talarico, Federica Di Cianni, Jeanette Andersen, Diana Marinello, Coralie Bouillot, Nathalie Costedoat-Chalumeau, Ellen Moholt, Chris Wincup, Valentin Ritschl, Christina Wettengl, Richard West, Loreto Carmona, Peter Böhm, Valentina Schmolik, Savino Sciascia, Ricard Cervera, Agnes Kocher, Laure Gossec, Bart J.F. van den Bemt, Sofia de Sousa Guimaraes Calado, Silivia Aguilera, Marta Mosca, Cristina Pamfil, Ravzan Dragoi, Vasco C. Romão, Farida Fortune
article en

Abstract

Low or nonadherence to treatment is a widespread challenge in the management of rheumatic and musculoskeletal diseases (RMDs), significantly affecting disease outcomes, quality of life, and healthcare costs. The 2020 European Alliance of Associations for Rheumatology (EULAR) Points to Consider provide a comprehensive framework for the prevention, screening, assessment, and management of nonadherence in RMDs. However, real-world implementation of these recommendations remains limited. The challenge is no longer the lack of recommendations, but their integration into routine rheumatology care. This viewpoint discusses the rationale and evidence supporting implementation of the 2020 EULAR Points to Consider in clinical practice and highlights key priorities for the operationalisation of the recommendations into feasible and sustainable care strategies. Particular emphasis is placed on routine adherence assessment, patient-centred communication, multidisciplinary collaboration, and healthcare professional training as essential components of adherence support in RMD care.

EULAR Rheumatology OpenVol. 2(4)
University of Pisa (IT), University of Modena and Reggio Emilia (IT), Inserm (FR), Queen Mary University of London (GB), University of the West of England (GB), University of Basel (CH), Université Paris Cité (FR), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Barts Health NHS Trust (GB), University Hospital of Basel (CH), Bristol Royal Infirmary (GB), Radboud University Medical Center (NL), Centre Hospitalier Universitaire de Lille (FR), Sorbonne Université (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Victor Babeș University of Medicine and Pharmacy Timișoara (RO), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Université Sorbonne Paris Nord (FR), Sorbonne Paris Cité (FR), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Diakonhjemmet Hospital (NO), Pitié-Salpêtrière Hospital (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Sint Maartenskliniek (NL), Ludwig Boltzmann Institute for Arthritis and Rehabilitation (AT), Scleroderma Foundation (US), Hospital de Santa Maria (PT), King's College Hospital (GB), Instituto de Salud Musculoesquelética (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Azienda Ospedaliera Universitaria Pisana (IT), Centre de Recherche Épidémiologie et Statistique (FR), University of Turin (IT), Université Lille Nord de France (FR), Universitat de Barcelona (ES), Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 8%
Medication Adherence and Compliance
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.